DNA‑Technology
DNA-Technology is a Moscow-based molecular diagnostics manufacturer founded in 1993 that develops real-time PCR instruments, laboratory automation systems, and over 100 PCR/LAMP reagent kits for clinical diagnostic laboratories, hospitals, and research institutions across more than 50 countries.
- Company typePrivate
- Founded1993
- HeadquartersMoscow, Russia
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What DNA‑Technology does
DNA-Technology LLC is a Moscow-based molecular diagnostics manufacturer founded in 1993 that develops, produces, and supplies PCR equipment, instruments, and consumables for clinical and research applications. The company serves clinical diagnostic laboratories, medical institutions and hospitals, and scientific research institutions, with a coverage of more than 50 distributors worldwide across Russia, Central Asia, Mongolia, and other regions. Its primary technology is polymerase chain reaction (PCR), including real-time PCR and LAMP (loop-mediated isothermal amplification), complemented by DNA/RNA extraction methodologies.
DNA‑Technology firmographics
Firmographics- Name
- DNA‑Technology
- Legal name
- DNA-Technology LLC
- Website
- https://dna-technology.com
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- DNA-Technology is a Moscow-based molecular diagnostics manufacturer founded in 1993 that develops real-time PCR instruments, laboratory automation systems, and over 100 PCR/LAMP reagent kits for clinical diagnostic laboratories, hospitals, and research institutions across more than 50 countries.
- Ownership category
- akta.pro rank
DNA‑Technology industry classification
Industry- Product category
- Molecular Diagnostics Equipment
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)
- akta.pro secondary industries
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
Keywords
Where DNA‑Technology is headquartered
LocationHeadquarters
- HQ city
- Moscow
- HQ country
- Russia
- HQ region
- Europe
Offices1 record
Markets served
DNA‑Technology business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure
Revenue model
- PCR Equipment Sales: Sale of real-time PCR instruments (DTprime, DTprime II, DTlite), PCR cabinets, DTstream dosing stations, DTpack microplate sealers, and general laboratory equipment.
- PCR and LAMP Reagent Kits: Sale of PCR detection kits for infectious diseases, genetics, microbiome analysis, HPV testing, and DNA/RNA extraction kits. Products include diagnostic kits for hepatitis, HIV, respiratory infections, sexually transmitted diseases, and other clinical applications.
- Transport Mediums: Sale of STOR-M and STOR-F transport mediums for biological sample collection and preservation.
- Software Licensing: Licensing of DTmaster and RealTime software for PCR instruments, including assay library distribution packages with test parameters and modules.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
DNA‑Technology product offering
Product offeringCore offering
DNA-Technology develops, manufactures, and supplies an integrated PCR-based molecular diagnostics ecosystem, comprising proprietary real-time PCR instruments (DTprime, DTprime II, DTlite), laboratory automation hardware (DTstream dosing stations, DTpack plate sealers, PCR cabinets), companion software (DTmaster, RealTime, DTintegrator), and an extensive portfolio of real-time PCR and LAMP reagent kits for infectious disease, HPV, microbiome, genetic, and pharmacogenetic testing, together with DNA/RNA extraction kits and transport media for clinical diagnostic and research laboratories.
Product overview
DNA-Technology is a Russian molecular diagnostics company that has been developing, producing, and introducing high-tech PCR equipment and reagent kits since 1993. The company offers a comprehensive ecosystem for polymerase chain reaction (PCR) diagnostics comprising: (1) Hardware instruments including DTprime II, DTprime, and DTlite real-time PCR detection systems; (2) Software platforms DTmaster and RealTime for instrument control and assay management; (3) Laboratory automation solutions including DTstream dosing stations and DTintegrator software for integrated laboratory management; (4) An extensive portfolio of over 100 REAL-TIME PCR and LAMP reagent kits organized by application: intestinal infections (BacScreen AEI 1, BacScreen AEI 2, Shigella/EIEC/Salmonella), respiratory infections (SARS-CoV-2 variants, Influenza A/B, Bordetella, Legionella, M.tuberculosis), sexually transmitted diseases (Chlamydia, Gonorrhea, Trichomonas, Mycoplasma multiplex panels), hepatitis and HIV, herpesviruses, human papillomavirus (HPV QUANT-21, HPV QUANT-15, HPV QUANT-4, HPV 16/18 Multiplex), microbiome composition analysis (FEMOFLOR series for vaginal, Androflor for male, ParodontoScreen for oral), genetics and pharmacogenetics (BRCA, EGFR, cystic fibrosis, thrombophilia, pharmacogenetics for clopidogrel/warfarin), prenatal diagnosis (Fetal RHD Genotyping, Fetal Gender), HLA typing, antibiotic resistance detection (BacResista, MRS/MRSA), mycoses (MycosoScreen), and high-threat pathogens (Bacillus anthracis, Yersinia pestis, Vibrio cholerae); (5) DNA/RNA extraction kits (PREP-NA, PREP-GS, PREP-OPTIMA, PREP-MB MAX, PREP-RAPID series); (6) Transport media (STOR-M, STOR-F); (7) Supporting laboratory equipment (PCR cabinet, DTpack microplate sealer, DTmag-16S magnetic rack, DTtherm dry bath, DTspin centrifuge-vortex, Thermit thermostat). The system enables complete PCR workflow automation from sample preparation to result detection.
Differentiator
Problem solved
Functional benefit
Products and services
- DTprime II Real-Time PCR Instrument
Quantifiable outcome
- Up to 800 samples can be dispensed during a workday
- +3 more outcomes
Companies that use DNA‑Technology
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
DNA‑Technology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration8 records
Feature9 records
DNA‑Technology partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ITGEL Erüül Mend CliniccoreDNA-Technology and the ITGEL Erüül Mend Clinic (Ulaanbaatar, Mongolia) have been working together for over a decade advancing modern molecular diagnostics technologies in Mongolia. This partnership represents a long-term strategic relationship focused on technology deployment and knowledge transfer in molecular diagnostics.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
DNA‑Technology competitors and assessment
Company assessmentDirect peers
- GeneProof: GeneProof is a Czech-based molecular diagnostics company specializing in PCR and real-time PCR kits for infectious diseases, genetic testing, and HPV. Its product portfolio and CE-marked positioning in EMEA closely overlap DNA-Technology's diagnostic kit business.
- Altona Diagnostics: Altona Diagnostics is a Hamburg-based molecular diagnostics company developing PCR kits for viral pathogens, including the AltoStar automation platform. It competes directly with DNA-Technology in real-time PCR reagent kits for infectious disease testing.
- ELITech Group: ELITech is a European mid-market molecular diagnostics company manufacturing PCR instruments (e.g., InGenius, ELITe InGenius) and a broad range of PCR kits — closely matching DNA-Technology's product mix and target market of clinical diagnostic labs. Both companies operate at similar scale and focus on integrated PCR workflow solutions.
Broad incumbents
- QIAGEN: QIAGEN's Rotor-Gene Q real-time PCR platform is a validated detection instrument for DNA-Technology's kits (HSV, Toxoplasma, Listeria). Both compete in nucleic acid extraction and PCR-based molecular diagnostics, with QIAGEN operating as a much larger global incumbent.
- Bio-Rad Laboratories: Bio-Rad is a major global life science and clinical diagnostics company whose CFX96 real-time PCR instrument is explicitly compatible with DNA-Technology's kits. Both serve clinical and research labs with PCR instruments and reagent kits, making Bio-Rad a direct technology-overlapping incumbent.
- Thermo Fisher Scientific (Applied Biosystems): Thermo Fisher's QuantStudio 5 real-time PCR system is officially compatible with DNA-Technology's diagnostic kits. Both compete in real-time PCR instruments and assay kits for clinical and research applications, with Thermo Fisher serving as a global breadth incumbent.
- Roche Diagnostics: Roche is a dominant global diagnostics player with the LightCycler real-time PCR system and cobas molecular diagnostics platform. DNA-Technology competes in the same clinical PCR testing category, though Roche operates at vastly greater scale and global reach.
- DiaSorin: DiaSorin is an Italian diagnostics company with a molecular diagnostics business (including the Liaison MDX platform) and a broad IVD portfolio. It competes in clinical PCR and infectious disease testing where DNA-Technology offers reagent kits.
- Cepheid (Danaher): Cepheid's GeneXpert is a leading molecular diagnostics platform for infectious disease PCR testing. It is a broader incumbent in the molecular diagnostics category where DNA-Technology competes, though Cepheid specializes in cartridge-based closed systems rather than open PCR workflows.
Regional players
- AmpliSens: AmpliSens is a Russian/CIS-focused molecular diagnostics company producing PCR kits for infectious diseases and genetic testing. It is the most direct Russian-language competitor to DNA-Technology in the domestic CIS market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
DNA‑Technology social profiles
Digital presenceDNA‑Technology compliance and trust
Trust signalCompliance8 records
DNA‑Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
DNA‑Technology leadership team
Management profileNumber of profiles
DNA‑Technology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DNA‑Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DNA‑Technology
What does DNA‑Technology do?
DNA-Technology develops, manufactures, and supplies an integrated PCR-based molecular diagnostics ecosystem, comprising proprietary real-time PCR instruments (DTprime, DTprime II, DTlite), laboratory automation hardware (DTstream dosing stations, DTpack plate sealers, PCR cabinets), companion software (DTmaster, RealTime, DTintegrator), and an extensive portfolio of real-time PCR and LAMP reagent kits for infectious disease, HPV, microbiome, genetic, and pharmacogenetic testing, together with DNA/RNA extraction kits and transport media for clinical diagnostic and research laboratories.
Is DNA‑Technology a public or private company?
DNA‑Technology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was DNA‑Technology founded?
DNA‑Technology was founded in 1993. It employs 101 to 250 people.
Where is DNA‑Technology based?
DNA‑Technology is headquartered in Moscow, Russia, in the Europe region.
How does DNA‑Technology make money?
Four revenue lines are on record. PCR Equipment Sales are the primary driver. The others are PCR and LAMP Reagent Kits, transport Mediums and software Licensing.
Who are DNA‑Technology's main competitors?
Direct peers on record are GeneProof, Altona Diagnostics and ELITech Group. Broad incumbents are QIAGEN, Bio-Rad Laboratories, Thermo Fisher Scientific (Applied Biosystems), Roche Diagnostics, DiaSorin and Cepheid (Danaher). AmpliSens is listed as a regional player.
Does DNA‑Technology have an API?
No public API is recorded for DNA‑Technology.
What industry is DNA‑Technology in?
DNA‑Technology's product category is Molecular Diagnostics Equipment. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 325413 and its SIC code is 2835.